Full-text resources of PSJD and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl
Preferences help
Polish version English version Language
enabled [disable] Abstract
Number of results

Results found: 1

Number of results on page
first rewind previous Page / 1 next fast forward last

Search results

help Sort By:

help Limit search:
first rewind previous Page / 1 next fast forward last
1
Publication available in full text mode
Content available

Cardiovascular and metabolic side effects of second-generation antipsychotics – narrative review

100%
Waszak P. M., Piskorska N. A., Sarbiewska M., Zagożdżon P., Cubała W. J.
European Journal of Translational and Clinical Medicine
|
2019
|
vol. 2
|
issue 1
70-77
EN
Since their introduction, the use of second generation antipsychotics (SGAs) has extended far beyond schizophrenia. With the increased usage of these agents, particular attention has been paid to their metabolic and cardiac side effects. This narrative review is an attempt to briefly summarize the conclusions from recently published systematic reviews on cardio-metabolic side effects of SGAs. Although no SGA is entirely free of these adverse effects, there are major differences in their prevalence between the specific medications. Numerous studies demonstrated particularly unfavorable side effect profiles of olanzapine and clozapine. The lack of conclusive data is a major limitation for many studies, particularly in the pediatric population. In this article we also discussed the meanings of these findings, suggested cardio-metabolic screening during SGA treatment and side effect management strategies.
first rewind previous Page / 1 next fast forward last
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.